She said Medtronic hopes to bring that combination to the U.S. market this calendar year, followed by developments with Abbott. “We will be addressing the sensor form factor issues and that’s going to ...

New Medtronic CFO Thierry Piéton. [Image from Mobilize Financial Services] Medtronic (NYSE: MDT) + announced today that it appointed Thierry Piéton as its new chief financial officer (CFO ...

The Medtronic Symplicty Spyral renal denervation ablation catheter expands inside the renal arteries. It ablates nerves in the vessel wall to treat hypertension. [Illustration courtesy of ...

Martha described Medtronic’s new Simplera Sync sensor as “half the size and much easier to apply than our previous sensor,” and said there are more sensors in the pipeline, as well as next-generation ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Medtronic’s diabetes business has turned around and is growing in the double digits, according to Martha, boosted by its technology for patients on intensive insulin therapy. The company’s Simplera ...

Among those presenting, Medtronic CEO Geoff Martha outlined multiple growth drivers in the pipeline, zeroing in on pulsed field ablation (PFA), renal denervation, neuromodulation and automated insulin ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other stocks on Jim Cramer's radar. Jim Cramer, host of Mad Money, recently emphasized the ...

Nobu Teranishi, Albert Theuwissen and Eric Fossum, who between them made key breakthroughs in the development of both CCD and CMOS sensors, have collaborated on an article for the open-access "Annual ...